1. Discovery of N-(2-Amino-4-Fluorophenyl)-4-[bis-(2-Chloroethyl)-Amino]-Benzamide as a Potent HDAC3 Inhibitor
   Yiming Chen et al, 2020, Frontiers in Oncology CrossRef
2. The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
   Yukio Tonozuka et al, 2024, Cancer Chemotherapy and Pharmacology CrossRef
3. HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
   Cancan Luo et al, 2022, Journal of Zhejiang University-SCIENCE B CrossRef
4. Identification of potential target genes of breast cancer in response to Chidamide treatment
   Han Han et al, 2022, Frontiers in Molecular Biosciences CrossRef
5. Insights into the Role of the Microbiota and of Short-Chain Fatty Acids in Rubinstein–Taybi Syndrome
   Elisabetta Di Fede et al, 2021, International Journal of Molecular Sciences CrossRef
6. A Novel Mechanism of Action of Histone Deacetylase Inhibitor Chidamide: Enhancing the Chemotaxis Function of Circulating PD-1(+) Cells From Patients With PTCL
   Chong Wei et al, 2021, Frontiers in Oncology CrossRef
7. Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications
   Rosario Castro-Oropeza et al, 2022, Frontiers in Genetics CrossRef
8. Chidamide: Targeting epigenetic regulation in the treatment of hematological malignancy
   Han‐Yu Cao et al, 2023, Hematological Oncology CrossRef
9. GZ17-6.02 interacts with proteasome inhibitors to kill multiple myeloma cells
   Laurence Booth et al, 2024, Oncotarget CrossRef
10. CKD-581 Downregulates Wnt/β-Catenin Pathway by DACT3 Induction in Hematologic Malignancy
    Soo Jin Kim et al, 2022, Biomolecules & Therapeutics CrossRef
11. Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
    Jacqueline Schütt et al, 2021, Cancers CrossRef
12. Chidamide Inhibits Acute Myeloid Leukemia Cell Proliferation by lncRNA VPS9D1-AS1 Downregulation via MEK/ERK Signaling Pathway
    Liman Lin et al, 2020, Frontiers in Pharmacology CrossRef
13. Venetoclax in combination with chidamide and dexamethasone in relapsed/refractory primary plasma cell leukemia without t(11;14): A case report
    Yang Yang et al, 2021, World Journal of Clinical Cases CrossRef
14. Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
    Yongpan Li et al, 2022, Stem Cells International CrossRef
15. Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma
    Linyan Xu et al, 2023, Journal of Pharmacology and Experimental Therapeutics CrossRef